Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine for prevention of COVID-19 in healthcare workers
RBR-4kjqtgPhase 2Completed
- Sponsor
- Universidade Federal de Goiás
- Start
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bcg vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Universidade Federal de Goiás. Primary endpoints: COVID-19 signs and symptoms, COVID-19 worsening and 1 more. Started Aug 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-4kjqtg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4kjqtg.